Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer's Disease.
Schino I, Cantore M, de Candia M, Altomare CD, Maria C, Barros J, Cachatra V, Calado P, Shimizu K, Freitas AA, Oliveira MC, Ferreira MJ, Lopes JNC, Colabufo NA, Rauter AP.
Schino I, et al. Among authors: rauter ap.
Pharmaceuticals (Basel). 2022 Dec 30;16(1):54. doi: 10.3390/ph16010054.
Pharmaceuticals (Basel). 2022.
PMID: 36678552
Free PMC article.